Activation of Microbubbles by Short-Pulsed Ultrasound Enhances the Cytotoxic Effect of Cis-Diamminedichloroplatinum (II) in a Canine Thyroid Adenocarcinoma Cell Line In Vitro

Ultrasound in Medicine and Biology

Volumn 38, Issue 1, 2012, Pages 109-118

  Sasaki, Noboru ^a   Kudo, Nobuki ^b   Nakamura, Kensuke ^a   Lim, Sue Yee ^a   Murakami, Masahiro ^a   Bandula Kumara, W R ^a   Tamura, Yu ^a   Ohta, Hiroshi ^a   Yamasaki, Masahiro ^a   Takiguchi, Mitsuyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Diagnostic ultrasound; Drug delivery; Ultrasound targeted microbubble destruction

Indexed keywords

ADENOCARCINOMA CELLS; CIS-PLATIN; CYTOTOXIC EFFECTS; DIAGNOSTIC ULTRASOUND; EFFICIENT DRUG DELIVERY; IN-VITRO; INCUBATION TIME; MICROBUBBLES; SHORT-PULSED; ULTRASOUND CONTRAST AGENT; ULTRASOUND TARGETED MICROBUBBLE DESTRUCTION;

CELL CULTURE; CELLS; CYTOTOXICITY; DRUG DELIVERY; GENES; PLATINUM COMPOUNDS;

ULTRASONICS;

CISPLATIN; PERFLUBUTANE;

ANIMAL CELL; ARTICLE; CARCINOMA CELL; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; IN VITRO STUDY; MICROBUBBLE; NONHUMAN; PRIORITY JOURNAL; SHORT PULSED ULTRASOUND; THYROID CARCINOMA; ULTRASOUND;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; CONTRAST MEDIA; DOGS; DRUG SYNERGISM; FERRIC COMPOUNDS; HIGH-ENERGY SHOCK WAVES; IRON; MICROBUBBLES; OXIDES; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 83055184134     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2011.09.017     Document Type: Article

References (42)

1. Chen S., Shohet R.V., Bekeredjian R., Frenkel P., Grayburn P.A. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol 2003, 42:301-308.
2. Chen S., Shimoda M., Wang M.Y., Ding J., Noguchi H., Matsumoto S., Grayburn P.A. Regeneration of pancreatic islets in vivo by ultrasound-targeted gene therapy. Gene Ther 2010, 17:1411-1420.
3. Chomas J.E., Dayton P., May D., Ferrara K.W. Threshold of fragmentation of ultrasonic contrast agents. J Biom Opt 2001, 6:141-150.
4. Chomas J.E., Dayton P., Allen J., Morgan K., Ferrara K.W. Mechanisms of contrast agent destruction. IEEE Trans Ultrason Ferroelectr Freq Control 2001, 48:232-248.
5. Crum L.A. Acoustic cavitation series: Part five rectified diffusion. Ultrasonics 1984, 22:215-223.
6. Dayton P.A., Morgan K.E., Kibanov A.L., Brandenburger G.H., Ferrara K.W. Optical and acoustical observations of the effects of ultrasound on contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control 1999, 46:220-232.
7. Duvshani-Eshet M., Adam D., Machluf M. The effects of albumin-coated microbubbles in DNA delivery mediated by therapeutic ultrasound. J Control Release 2006, 112:156-166.
8. Eisenbrey J.R., Soulen M.C., Wheatley M.A. Delivery of encapsulated doxorubicin by ultrasound-mediated size reduction of drug-loaded polymer contrast agents. IEEE Trans Biomed Eng 2010, 57:24-28.
9. Fabiilli M.L., Haworth K.J., Sebastian I.E., Kripfgans O.D., Carson P.L., Fowlkes J.B. Delivery of chlorambucil using an acoustically-triggered perfluoropentane emulsion. Ultrasound Med Biol 2010, 36:1364-1375.
10. Geis N.A., Mayer C.R., Kroll R.D., Hardt S.E., Katus H.A., Bekeredjian R. Spatial distribution of ultrasound targeted microbubble destruction increases cardiac transgene expression but not capillary permeability. Ultrasound Med Biol 2009, 35:1119-1126.
11. Iwanaga K., Tominaga K., Yamamoto K., Habu M., Maeda H., Akifusa S., Tsujisawa T., Okinaga T., Fukuda J., Nishihara T. Local delivery system of cytotoxic agents to tumors by focused sonoporation. Cancer Gene Ther 2007, 14:354-363.
12. Karshafian R., Bevan P.D., Williams R., Samac S., Burns P.N. Sonoporation by ultrasound-activated microbubble contrast agents: Effect of acoustic exposure parameters on cell membrane permeability and cell viability. Ultrasound Med Biol 2009, 35:847-860.
13. Kindberg G.M., Tolleshaug H., Roos N., Skotland T. Hepatic clearance of Sonazoid perfluorobutane microbubbles by Kupffer cells does not reduce the ability of liver to phagocytose or degrade albumin microspheres. Cell Tissue Res 2003, 312:49-54.
14. Kinoshita M., Hynynen K. Key factors that affect sonoporation efficiency in in vitro settings: The importance of standing wave in sonoporation. Biochem Biophys Res Commun 2007, 359:860-865.
15. Kobulnik J., Kuliszewski M.A., Stewart D.J., Lindner J.R., Leong-Poi H. Comparison of gene delivery techniques for therapeutic angiogenesis: Ultrasound-mediated destruction of carrier microbubbles versus direct intramuscular injection. J Am Coll Cardiol 2009, 54:1735-1742.
16. Kudo N., Okada K., Yamamoto K. Sonoporation by single-shot pulsed ultrasound with microbubbles adjacent to cells. Biophys J 2009, 96:4866-4876.
17. Lai C.Y., Wu C.H., Chen C.C., Li P.C. Quantitative relations of acoustic inertial cavitation with sonoporation and cell viability. Ultrasound Med Biol 2006, 32:1931-1941.
18. Lamb H. Hydrodynamics 1932, Dover Publications, New York. sixth edition.
19. Larina I.V., Evers B.M., Esenaliev R.O. Optimal drug and gene delivery in cancer cells by ultrasound-induced cavitation. Anticancer Res 2005, 25:149-156.
20. Lawrie A., Brisken A.F., Francis S.E., Cumberland D.C., Ccrossman D.C., Newman C.M. Microbubble-enhanced ultrasound for vascular gene delivery. Gene Ther 2000, 7:2023-2027.
21. Mehier-Humbert S., Bettinger T., Yan F., Guy R.H. Plasma membrane poration induced by ultrasound exposure: Implication for drug delivery. J Control Release 2005, 104:213-222.
22. Meijering B.D.M., Henning R.H., van Gilst W.H., Gavrilovic I., van Wamel A., Deelman L.E. Optimization of ultrasound and microbubbles targeted gene delivery to cultured primary endothelial cells. J Drug Target 2007, 15:664-671.
23. Meijering B.D.M., Juffermans L.J.M., van Wamel A., Henning R.H., Zuhorn I.S., Emmer M., Versteilen A.M.G., Paulus W.J., van Gilst W.H., Kooiman K., de Jong N., Musters R.J.P., Deelman L.E., Kamp O. Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation. Circ Res 2009, 104:679-687.
24. Milburn G.H.W., Truter M.R. The crystal structures of cis- and trans-Dichlorodiammineplatinum(II). J Chem Soc (A) 1966, 1609-1616.
25. Miller D.L., Quddus J. Sonoporation of monolayer cells by diagnostic ultrasound activation of contrast-agent gas bodies. Ultrasound Med Biol 2000, 26:661-667.
26. Pislaru S.V., Pislaru C., Kinnick R.R., Singh R., Gulati R., Greenleaf J.F., Simari R.D. Optimization of ultrasound-mediated gene transfer: Comparison of contrast agents and ultrasound modalities. Eur Heart J 2003, 24:1690-1698.
27. Postema M., van Wamel A., Lancée C.T., de Jong N. Ultrasound-induced encapsulated microbubble phenomena. Ultrasound Med Biol 2004, 30:827-840.
28. Schlicher R.K., Radhakrishna H., Tolentino T.P., Apkarian R.P., Zarnitsyn V., Prausnitz M.R. Mechanism of intracellular delivery by acoustic cavitation. Ultrasound Med Biol 2006, 32:915-924.
29. Shi W.T., Forsberg F., Tornes A., Østensen J., Goldberg B.B. Destruction of contrast microbubbles and the association with inertial cavitation. Ultrasound Med Biol 2000, 26:1009-1019.
30. Shi W.T., Forsberg F., Vaidyanathan P., Tornes A., Østensen J., Goldberg B.B. The influence of acoustic transmit parameters on the destruction of contrast microbubbles in vitro. Phys Med Biol 2006, 51:4031-4045.
31. Shohet R.V., Chen S., Zhou Y.T., Wang Z., Meidell R.S., Unger R.H., Grayburn P.A. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 2000, 101:2554-2556.
32. Sonoda S., Tachibana K., Uchino E., Yamashita T., Sakoda K., Sonoda K.H., Hisatomi T., Izumi Y., Sakamoto T. Inhibition of melanoma by ultrasound-microbubble-aided drug delivery suggests membrane permeabilization. Cancer Biol Ther 2007, 6:1282-1289.
33. Sontum P.C., Østensen J., Dyrstad K., Hoff L. Acoustic properties of NC100100 and their relation with the microbubble size distribution. Invest Radiol 1999, 34:268-275.
34. Taniyama Y., Tachibana K., Hiraoka K., Namba T., Yamasaki K., Hashiya N., Aoki M., Ogihara T., Kaneda Y., Morishita R. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 2002, 105:1233-1239.
35. Tartis M.S., McCallan J., Lum A.F.H., LaBell R., Stieger S.M., Matsunaga T.O., Ferrara K.W. Therapeutic effects of paclitaxel-containing ultrasound contrast agents. Ultrasound Med Biol 2006, 32:1771-1780.
36. Tinkov S., Coester C., Serba S., Geis N.A., Katus H.A., Winter G., Bekeredjian R. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: In vivo characterization. J Control Release 2010, 148:368-372.
37. Vannan M., McCreery T., Li P., Han Z., Unger E., Kuersten B., Nabel E., Rajagopalan S. Ultrasound-mediated transfection of canine myocardium by intravenous administration of cationic microbubble-linked plasmid DNA. J Am Soc Echocardiogr 2002, 15:214-218.
38. van Wamel A., Kooiman K., Harteveld M., Emmer M., ten Cate F.J., Versluis M., de Jong N. Vibrating microbubbles poking individual cells: Drug transfer into cells via sonoporation. J Control Release 2006, 112:149-155.
39. Wang Y., Zhou J., Zhang Y., Wang X., Chen J. Delivery of TFPI-2 using Sonovue and adenovirus results in the suppression of thrombosis and arterial re-stenosis. Exp Biol Med 2010, 235:1072-1081.
40. Watanabe Y., Aoi A., Horie S., Tomita N., Mori S., Morikawa H., Matsumura Y., Vassaux G., Kodama T. Low-intensity ultrasound and microbubbles enhance the antitumor effect of cisplatin. Cancer Sci 2008, 99:2525-2531.
41. Zhao Y.Z., Lu C.T., Zhou Z.C., Jin Z., Zhang L., Sun C.Z., Xu Y.Y., Gao H.S., Tian J.L., Gao F.H., Tang Q.Q., Li W., Xiang Q., Li X.K., Li W.F. Enhancing chemotherapeutic drug inhibition on tumor growth by ultrasound: An in vivo experiment. J Drug Target 2011, 19:154-160.
42. Zhou Y., Kumon R.E., Cui J., Deng C.X. The size of sonoporation pores on the cell membrane. Ultrasound Med Biol 2009, 35:1756-1760.